RECOPS Spain: What It Is and Who Must Register (AEMPS)
The Spanish Agency of Medicines and Medical Devices (AEMPS) has launched RECOPS, the new electronic application for the Registry of Commercialization of Medical…
AML Global Partners provides regulatory affairs consulting services for pharmaceuticals, medical devices, food supplements and cosmetics in the EU, the United States, the GCC and other international markets, without the delays and overhead of a large consultancy.
From the first regulatory strategy to market authorisation and post-market obligations, we act as your regulatory affairs team: we prepare the dossiers, deal with the competent authorities of each market (from the EMA, ECHA and national agencies to the FDA and GCC regulators) and keep your products compliant once they are on the market.
Medicinal product registration with the EMA and AEMPS, CTD/eCTD dossiers, lifecycle variations and GMP compliance consulting.
02CE marking under EU MDR 2017/745, technical documentation, EU Authorised Representative and AEMPS registration in RECOPS.
03AESAN and EU notifications, label and health claims review, and novel food assessments across multiple countries.
04CPNP notification, safety assessment, PIF preparation and EU Responsible Person services under Regulation (EC) No 1223/2009.
05REACH registration, CLP classification, safety data sheets and UFI notification with ECHA.
06Stability, challenge and efficacy testing through accredited laboratories, with data ready for your regulatory submission.
We review your product, its classification and your target markets, and define the fastest compliant route to market with a clear timeline.
We prepare the technical documentation, submit it to the competent authorities and handle their questions until the product is authorised or notified.
After launch we manage variations, renewals, vigilance and regulatory changes, either per project or as your outsourced regulatory affairs function.
You work with the specialists, not account managers. Every engagement is handled by regulatory scientists and chemists who know your regulatory framework inside out.
We run lean by design. Without the layers of a large consultancy, we move faster.
We hold active regulatory experience across the EU, US, GCC and Asian markets, including territories most consultancies rarely cover.
The Spanish Agency of Medicines and Medical Devices (AEMPS) has launched RECOPS, the new electronic application for the Registry of Commercialization of Medical…
Submitting a commercialization notification through RECOPS (Registro de Comercialización de Productos Sanitarios) is a mandatory requirement for economic operat…
The regulatory framework for food supplements in Spain is evolving rapidly. In 2026, the Spanish Agency for Food Safety and Nutrition (AESAN) has increased scru…
A regulatory affairs consultancy helps manufacturers place products on the market legally. It defines the regulatory strategy, prepares the technical dossiers, submits them to the competent authorities (such as the EMA, the FDA or national agencies) and keeps products compliant after launch through variations, renewals and vigilance.
Medicinal products, medical devices and in vitro diagnostics, food supplements, cosmetics and chemicals under REACH and CLP. See our regulatory affairs services by sector.
We work internationally: the European Union, the United Kingdom, the United States (FDA), the GCC countries and other markets in Asia. Each authority has its own rules, so we coordinate the requirements of every market in parallel to keep your launch dates aligned.
Yes. Besides one-off projects, such as a registration, a notification or a dossier, we can take on your regulatory affairs function on an ongoing basis, so you do not need to build an in-house team.
Ideally before development is closed: classification, formulation and labelling decisions made early avoid reformulations and delays later. It also makes sense when entering a new market, when regulations change (as with EU MDR) or when your team lacks capacity.
Tell us your product and target markets. We will identify your fastest, cleanest route to compliance and start working on it immediately.